Identification of Lower Grade Glioma Antigens Based on Ferroptosis Status for mRNA Vaccine Development
CONCLUSION: HOTAIR, IDO1, KIF20A, NR5A2, and RRM2 were identified as promising candidate antigens for the development of an LGG mRNA vaccine, particularly offering potential benefits to FS2 and FS4 patients.PMID:38623558 | PMC:PMC11018127 | DOI:10.2147/PGPM.S449230
Source: Cancer Control - Category: Cancer & Oncology Authors: Zhenxiang Zhao Na Xing Hao Guo Jianfeng Li Guozhu Sun Source Type: research
More News: Brain Tumor | Cancer | Cancer & Oncology | Cancer Vaccines | China Health | Databases & Libraries | Genetics | Glioma | Immunotherapy | Study | Vaccines